Template:Selected biological properties of endogenous estrogens in rats

From HandWiki
v · d · e Selected biological properties of endogenous estrogens in rats
Estrogen ER RBA (%) Uterine weight (%) Uterotrophy LH levels (%) SHBG RBA (%)
Control 100 100
Estradiol 100 506 ± 20 +++ 12–19 100
Estrone 11 ± 8 490 ± 22 +++ ? 20
Estriol 10 ± 4 468 ± 30 +++ 8–18 3
Estetrol 0.5 ± 0.2 ? Inactive ? 1
17α-Estradiol 4.2 ± 0.8 ? ? ? ?
2-Hydroxyestradiol 24 ± 7 285 ± 8 +b 31–61 28
2-Methoxyestradiol 0.05 ± 0.04 101 Inactive ? 130
4-Hydroxyestradiol 45 ± 12 ? ? ? ?
4-Methoxyestradiol 1.3 ± 0.2 260 ++ ? 9
4-Fluoroestradiola 180 ± 43 ? +++ ? ?
2-Hydroxyestrone 1.9 ± 0.8 130 ± 9 Inactive 110–142 8
2-Methoxyestrone 0.01 ± 0.00 103 ± 7 Inactive 95–100 120
4-Hydroxyestrone 11 ± 4 351 ++ 21–50 35
4-Methoxyestrone 0.13 ± 0.04 338 ++ 65–92 12
16α-Hydroxyestrone 2.8 ± 1.0 552 ± 42 +++ 7–24 <0.5
2-Hydroxyestriol 0.9 ± 0.3 302 +b ? ?
2-Methoxyestriol 0.01 ± 0.00 ? Inactive ? 4
Notes: Values are mean ± SD or range. ER RBA = Relative binding affinity to estrogen receptors of rat uterine cytosol. Uterine weight = Percentage change in uterine wet weight of ovariectomized rats after 72 hours with continuous administration of 1 μg/hour via subcutaneously implanted osmotic pumps. LH levels = Luteinizing hormone levels relative to baseline of ovariectomized rats after 24 to 72 hours of continuous administration via subcutaneous implant. Footnotes: a = Synthetic (i.e., not endogenous). b = Atypical uterotrophic effect which plateaus within 48 hours (estradiol's uterotrophy continues linearly up to 72 hours). Sources: [1][2][3][4][5][6][7][8][9]
Template documentation

See also

References

  1. "Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15alpha,16alpha,17beta-tetrol)". Steroids 27 (3): 325–33. March 1976. doi:10.1016/0039-128x(76)90054-4. PMID 178074. 
  2. "Direction of estradiol metabolism as a control of its hormonal action--uterotrophic activity of estradiol metabolites". Endocrinology 101 (6): 1709–15. December 1977. doi:10.1210/endo-101-6-1709. PMID 590186. 
  3. "Differential biological activity of estradiol metabolites". Pediatrics 62 (6 Pt 2): 1128–33. December 1978. PMID 724350. https://pediatrics.aappublications.org/content/62/6/1128. 
  4. "Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion". Endocrinology 105 (6): 1288–92. December 1979. doi:10.1210/endo-105-6-1288. PMID 499073. 
  5. Fishman, J.; Martucci, C. P. (1980). "New Concepts of Estrogenic Activity: the Role of Metabolites in the Expression of Hormone Action". The Menopause and Postmenopause. pp. 43–52. doi:10.1007/978-94-011-7230-1_5. ISBN 978-94-011-7232-5. 
  6. "Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology". J. Clin. Endocrinol. Metab. 51 (3): 611–5. September 1980. doi:10.1210/jcem-51-3-611. PMID 7190977. 
  7. "The role of 2-methoxyestrone in estrogen action". J. Steroid Biochem. 19 (1B): 635–8. July 1983. doi:10.1016/0022-4731(83)90229-7. PMID 6310247. 
  8. John A. McLachlan, ed. "Dissociation of biological activities in metabolites of estradiol". Estrogens in the Environment: Proceedings of the Symposium on Estrogens in the Environment, Raleigh, North Carolina, U.S.A., September 10-12, 1979. Elsevier. pp. 131–145. ISBN 9780444003720. https://books.google.com/books?id=eu5qAAAAMAAJ. 
  9. "Pharmacology of estrogens and progestogens: influence of different routes of administration". Climacteric 8 Suppl 1: 3–63. 2005. doi:10.1080/13697130500148875. PMID 16112947. http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf.